DAR

Business Context and Reporting Period

Company: Darling International Inc. (now Darling Ingredients Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended September 27, 2008
Business Overview: A leading provider of rendering, recycling, and recovery solutions to the food industry. Operations are organized into two segments: Rendering (processing animal by-products into oils and proteins) and Restaurant Services (collecting used cooking oil and grease trap servicing).

Key Financial Metrics

Segment Profit (9 Months 2008): Rendering ($106.2M), Restaurant Services ($34.2M), Corporate ($69.5M loss).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 37.5% in Q3 and 40.2% for the nine-month period, driven primarily by significantly higher finished product commodity prices (MBM, BFT, YG).
• Profitability: Operating income rose 77.6% in Q3 and 102.3% for the nine-month period. Net income more than doubled in both periods.
• Cost Pressures: Cost of sales increased due to higher raw material costs (linked to finished goods pricing formulas) and elevated energy costs (natural gas and diesel) which peaked in Q3.
• Acquisition: Completed the acquisition of API Recycling's used cooking oil collection business on August 25, 2008, for approximately $17.4 million.
• Bad Debt: Increased provision for bad debt expense due to delinquent accounts receivable and tight credit markets.

Outlook, Risks, and Management Commentary

• Commodity Volatility: Management notes that while prices were strong in Q3, finished product prices began declining in the latter part of the quarter and continued to drop significantly in October 2008. This poses a risk to future earnings.
• Energy Costs: Energy prices (natural gas and diesel) declined in Q4 2008, which may offset some cost pressures, though volatility remains a challenge.
• Regulatory Risks: The FDA's "Final BSE Rule" (effective April 2009) may require capital expenditures and could impact raw material volumes. The company is awaiting further guidance.
• Financial Crisis Impact: The global financial crisis has led to reduced liquidity for suppliers and customers, increasing bad debt risks and potentially reducing raw material volumes.
• Liquidity: The company maintains a strong balance sheet with $43.2 million in unrestricted cash and $108.6 million available under its revolving credit facility. It is in compliance with all debt covenants.
• Guidance: No specific numerical guidance was provided for the full year, but management cautioned that Q3 results may not be indicative of future performance due to the volatile economic environment.

Key Facts for Investor Verification

• Price Sensitivity: Verify the correlation between current commodity prices (MBM, BFT, YG) and the company's revenue, as formula-based raw material costs may compress margins if prices fall.
• Bad Debt Exposure: Monitor the trend in accounts receivable and bad debt provisions given the tight credit market and potential supplier/customer insolvencies.
• Regulatory Compliance Costs: Assess the potential capital expenditure required to comply with the FDA's Final BSE Rule effective April 2009.
• Energy Hedging: Review the company's strategy for managing natural gas and diesel costs, including the use of alternative fuels and tax credits.
• Debt Covenants: Confirm continued compliance with the Credit Agreement's leverage ratio (currently < 2.00 to 1.00) amidst potential earnings volatility.